Arunothayaraj Sandeep, Egred Mohaned, Banning Adrian P, Brunel Philippe, Ferenc Miroslaw, Hovasse Thomas, Wlodarczak Adrian, Pan Manuel, Schmitz Thomas, Silvestri Marc, Erglis Andreis, Kretov Evgeny, Lassen Jens Flensted, Chieffo Alaide, Lefèvre Thierry, Burzotta Francesco, Cockburn James, Darremont Olivier, Stankovic Goran, Morice Marie-Claude, Louvard Yves, Hildick-Smith David
Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK (S.A., J.C., D.H.-S.).
Department of Cardiology, Freeman Hospital & Newcastle University, Newcastle upon Tyne, UK (M.E.).
Circulation. 2025 Mar 4;151(9):612-622. doi: 10.1161/CIRCULATIONAHA.124.071153. Epub 2025 Feb 5.
The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European Bifurcation Club Left Main Trial) aimed to evaluate clinical outcomes of a stepwise provisional strategy compared with a systematic dual-stent approach.
EBC MAIN was a randomized, investigator-initiated, open-label, multicenter, parallel-group trial conducted across 35 hospitals in 11 European countries. A total of 467 participants undergoing percutaneous coronary intervention for unprotected true left main bifurcation lesions were randomly assigned to the stepwise provisional strategy (n=230) or an upfront dual-stent approach (n=237). The mean (SD) age was 71 (10) years and 23% of participants were women. The primary end point was a composite of major adverse cardiac events, defined as all-cause mortality, all myocardial infarction, or clinically driven target lesion revascularization. Events were adjudicated by an independent clinical events committee and all analyses were by the intention-to-treat principle.
At 3 years, the primary end point occurred in 54 of 230 (23.5%) stepwise provisional and 70 of 237 (29.5%) dual-stent patients (hazard ratio, 0.75 [95% CI, 0.53-1.07]; =0.11). There was no significant difference in all-cause mortality (10.0% versus 13.1%) or myocardial infarction (12.2% versus 11.0%). However, target lesion revascularization was significantly lower in the stepwise provisional group (8.3% versus 15.6%; hazard ratio, 0.50 [95% CI, 0.29-0.86]; =0.013). In this population, the mean side vessel diameter by quantitative angiography was 2.9 mm, and median side vessel lesion length was 5 mm. Significant interactions were identified between the assigned bifurcation strategy and both side vessel diameter and lesion length with respect to the primary outcome (=0.009 and =0.005, respectively), with smaller vessels (<3.25 mm diameter) and shorter lesions (<10 mm length) favoring the provisional approach.
In a European population with true left main stem bifurcation coronary disease requiring intervention, there was no difference in major adverse cardiovascular events between stepwise provisional and systematic dual-stent strategies at 3 years. Target lesion revascularization was significantly less frequent with the stepwise provisional approach, which should be the default strategy for noncomplex left main bifurcation coronary intervention.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT02497014.
对于真性左主干分叉病变,最佳的冠状动脉支架置入技术尚不确定。欧洲分叉俱乐部左主干试验(EBC MAIN)旨在评估逐步临时策略与系统性双支架置入方法相比的临床结局。
EBC MAIN是一项由研究者发起的随机、开放标签、多中心、平行组试验,在11个欧洲国家的35家医院进行。共有467例因未保护的真性左主干分叉病变接受经皮冠状动脉介入治疗的参与者被随机分配至逐步临时策略组(n = 230)或初始双支架置入方法组(n = 237)。平均(标准差)年龄为71(10)岁,23%的参与者为女性。主要终点是主要不良心脏事件的复合终点,定义为全因死亡、所有心肌梗死或临床驱动的靶病变血运重建。事件由独立的临床事件委员会判定,所有分析均遵循意向性治疗原则。
3年时,逐步临时策略组230例中有54例(23.5%)、双支架置入组237例中有70例(29.5%)发生主要终点事件(风险比,0.75[95%CI,0.53 - 1.07];P = 0.11)。全因死亡率(10.0%对13.1%)或心肌梗死发生率(12.2%对11.0%)无显著差异。然而,逐步临时策略组的靶病变血运重建率显著更低(8.3%对15.6%;风险比,0.50[95%CI,0.29 - 0.86];P = 0.013)。在该人群中,定量血管造影显示的平均边支血管直径为2.9 mm,边支血管病变长度中位数为5 mm。就主要结局而言,在分配的分叉策略与边支血管直径和病变长度之间均发现了显著的交互作用(分别为P = 0.009和P = 0.005),较小的血管(直径<3.25 mm)和较短的病变(长度<10 mm)更有利于临时策略。
在欧洲需要干预的真性左主干分叉冠状动脉疾病人群中,3年时逐步临时策略与系统性双支架策略在主要不良心血管事件方面无差异。逐步临时策略的靶病变血运重建频率显著更低,应作为非复杂性左主干分叉冠状动脉介入的默认策略。